Rubric Capital Management LP 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-17 4:32 pm Purchase |
2024-06-17 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 108,486,735 14.200% |
8,771,750 (+8.80%) |
Filing |
| 2024-04-16 2:58 pm Purchase |
2024-04-15 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 99,714,985 14.220% |
10,100 (+0.01%) |
Filing |
| 2023-11-20 08:45 am Purchase |
2023-11-16 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 99,704,885 14.220% |
2,378,330 (+2.44%) |
Filing |
| 2023-11-15 07:56 am Purchase |
2023-11-13 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 97,326,555 13.880% |
7,200 (+0.01%) |
Filing |
| 2023-11-13 07:31 am Purchase |
2023-11-09 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 97,319,355 13.880% |
1,758,195 (+1.84%) |
Filing |
| 2023-11-08 07:06 am Purchase |
2023-11-06 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 95,561,160 13.630% |
2,188,575 (+2.34%) |
Filing |
| 2023-11-06 07:30 am Purchase |
2023-11-03 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 93,372,585 13.320% |
1,081,380 (+1.17%) |
Filing |
| 2023-11-02 07:30 am Purchase |
2023-10-31 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 92,291,205 13.250% |
92,130 (+0.10%) |
Filing |
| 2023-10-30 6:02 pm Purchase |
2023-10-27 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 92,199,075 13.150% |
2,168,475 (+2.41%) |
Filing |
| 2023-06-16 08:00 am Purchase |
2023-06-14 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 90,030,600 14.410% |
6,250,000 (+7.46%) |
Filing |
| 2022-10-28 1:17 pm Unchanged |
2022-10-28 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 83,780,600 13.410% |
0 (Unchanged) |
Filing |
| 2022-09-23 4:18 pm Unchanged |
2022-09-15 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 83,780,600 13.410% |
0 (Unchanged) |
Filing |
| 2022-08-23 6:31 pm Purchase |
2022-08-19 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 83,780,600 14.320% |
1,507,790 (+1.83%) |
Filing |
| 2022-06-14 10:21 am Purchase |
2022-06-13 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 82,272,810 14.070% |
5,480,185 (+7.14%) |
Filing |
| 2022-06-09 08:00 am Purchase |
2022-06-09 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 76,792,625 13.129% |
1,792,625 (+2.39%) |
Filing |
| 2022-05-26 5:29 pm Purchase |
2022-05-26 | 13D | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 75,000,000 12.820% |
427,765 (+0.57%) |
Filing |
| 2022-02-14 08:50 am Purchase |
2021-12-31 | 13G | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 74,572,235 13.700% |
18,072,235 (+31.99%) |
Filing |
| 2021-12-02 2:31 pm Purchase |
2021-09-30 | 13G | Mereo BioPharma Group plc MREO |
Rubric Capital Management LP | 56,500,000 10.380% |
56,500,000 (New Position) |
Filing |